
Maybe coronavirus' aggressiveness could be changed by adding
or subtracting sugar molecules
Scientists have been tracking changes to the genetic makeup of the new coronavirus to better understand how best to slow its spread. My research on the from the virus could provide insight into the nature of different possible types of virus. Specifically, the presence of sugar on the virus’s spike protein could help differentiate them.
Many physicians noticed that people with high blood sugar, not only those with a history of diabetes but also with the novel coronavirus. This indicated to me that something could be going on with the addition of sugar molecules to the virus, or the receptor it latches onto to infect cells, that .
at the University of Pittsburgh who treats women with breast cancer. Colleagues of mine at the University of Pennsylvania have to try to keep breast cancer from growing in the bone marrow, only to regrow years later. We call this tumor dormancy.
It turns out that among other things, , lowering blood sugar.
This led me to hypothesize that the by adding of sugar molecules to the coat of the virus and its receptor.
I was therefore very interested in finding out whether there were mutations in the virus that possibly added or subtracted sugar molecules from the virus proteins, and therefore possibly either increased or decreased the severity of disease.
Sequencing novel coronavirus and scanning for mutation
Unlike prior pandemics, we have a new and very powerful tool in 2020. We are able to obtain the RNA sequence of the virus almost in real time, and track the changes in the virus as it moves from place to place.
These coronaviruses do mutate quite a bit. A group of dedicated scientists who are members of a research organization called have been doing this, and another group called has created a website to allow the public to see the mutations in real time. It is open source, meaning anyone can use it.
What I found (like many others) when looking through this database was that there appeared to be a . The virus has specific areas where sugar is added when it replicates in cells, and the mutation appeared to increase the likelihood that a sugar molecule would be added to one of these areas. affected the ability of those viruses to fuse with cells.
What was interesting was that this mutation, called D614G, seemed to be , and the disease seemed to be more severe on the East Coast.

While a causal link between this mutation and more severe disease remains to be proven, this may explain at least part of the difference between the severity of infections on the East and West coasts. among other mutations of the novel coronavirus taken from various people infected in Wuhan can alter the aggressiveness of the virus in cells grown in the lab. For example, strains of the novel coronavirus in Wuhan that were more similar to those in Washington and California were less aggressive in cell culture than those that were more similar to Europe.
While only a theory, this could mean that the novel coronavirus is trying out various strategies to try to live with us. by putting too many people in the hospital so it cannot spread. The milder form of the virus could spread more, and provide more immunity. Therefore, the novel coronavirus could be losing aggressiveness at it continues to move among us. This clearly is crucial to know, and needs to be tested.
Many scientists around the world are trying to figure this out. It’s interesting what a clinical observation can lead to.
This article is republished from under a Creative Commons license. Read the .
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles

What’s in a diagnosis?
When Jessica Foglio’s son Ben was first diagnosed with cerebral palsy, the label didn’t feel right. Whole exome sequencing revealed a rare disorder called Salla disease. Now Jessica is building community and driving research for answers.

Peer through a window to the future of science
Aaron Hoskins of the University of Wisconsin–Madison and Sandra Gabelli of Merck, co-chairs of the 2026 ASBMB annual meeting, to be held March 7–10, explain how this gathering will inspire new ideas and drive progress in molecular life sciences.

Glow-based assay sheds light on disease-causing mutations
University of Michigan researchers create a way to screen protein structure changes caused by mutations that may lead to new rare disease therapeutics.

How signals shape DNA via gene regulation
A new chromatin isolation technique reveals how signaling pathways reshape DNA-bound proteins, offering insight into potential targets for precision therapies. Read more about this recent ɬÀï·¬ paper.

A game changer in cancer kinase target profiling
A new phosphonate-tagging method improves kinase inhibitor profiling, revealing off-target effects and paving the way for safer, more precise cancer therapies tailored to individual patients. Read more about this recent ɬÀï·¬ paper.

How scientists identified a new neuromuscular disease
NIH researchers discover Morimoto–Ryu–Malicdan syndrome, after finding shared symptoms and RFC4 gene variants in nine patients, offering hope for faster diagnosis and future treatments.